We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
I am the Head of Procurement for Civica, one of West’s customers.
Civica is working to solve two big problems in U.S. healthcare - drug shortages and predatory pricing. Our mission is to ensure quality generic and biosimilar medications are available and affordable to everyone.
We are able to achieve our mission because we work collaboratively with drug manufacturers and partners, like West. Together, we work to make sure hospitals have the medicines they need for their patients.
Civica is a non-profit organization, so for us it’s not about market share, it’s about doing the right thing. From the very beginning, the No. 1 Policy for the Civica family has been ‘Do what is in the best interest of patients’.
We recently announced we are going to develop, manufacture, and distribute three of the most commonly used insulins, in addition to essential generic medicines for hospitals. These insulins will be priced at no more than $30 per vial and $55 per pack of five pre-filled pens.
When we look to the future, we are pleased to be able to continue to work with partners like West – as we work to make a difference to the lives of individuals and families across the United States.
Happy 100th
On behalf of Civica, I’d like to wish West a Happy 100th anniversary and send congratulations on this incredible accomplishment.
We’re looking forward to creating new milestones together in the years to come. We’d like to thank West team members for their ongoing partnership, expertise, and support of our mission. Ensuring patients have the medications they need, when they need them.
When choosing a resource for laboratory testing, pharmaceutical manufacturers face a difficult decision. Which is the better option – an independent facility or a supplier-affiliated laboratory?
Particles in parenteral drug products continue to be an important concern. At the April-2017 AAPS Workshop <strong>Challenges and Patient Impact of Particles in Biologics</strong>, Fran DeGrazio, VP of Scientific Affairs and Technical Services, spoke on the topic: <em>Unique Considerations for Testing and Understanding Particle Loads for Primary Packaging Components.</em> <br />
Cell and gene therapies are an expanding area with an expected growth rate of 24.7% over the forecast period of 2022-2030 .<sup>1</sup><br />Vial-stopper-seal combinations used as containment systems for these therapies need to maintain container closure integrity (CCI) for extended periods. Achieving CCI can be a particular challenge due to the low storage temperatures required: ultra-low (-80°C) for gene therapies and cryogenic (≤ -130°C, i.e., vapor of liquid nitrogen) for cell therapies.
As scientists continue to gain a better understanding of the Corona virus, we are witness to a growing number of novel and repurposed therapeutics in development along with clinical trials designed to attack multiple aspects of the unique clinical pathologies. On the vaccine side, manufacturers are trying a multi-pronged approach to stimulate the immune system by using both traditional approaches (i.e., protein subunits, inactivated viruses, and virus-like particles) and novel platforms that are based on delivery of mRNA, DNA, or non-replicating viral vectors that can trigger the body to make the viral proteins themselves. The typical timelines, not counting the time it takes to demonstrate safety and efficacy of these vaccines, can range from months to years and even up to a decade to successfully design, manufacture and consistently produce high quality vaccines.
Our team in Israel, along with the rest of the world, have had a very challenging time due to the COVID-19 pandemic. In Israel, charities supporting youth in need have found this time to be particularly tough. As a result, the team came up with a novel and environmentally friendly solution to help support some of the youth in their local community.
English
Chinese
